Astrology has always captivated humanity, offering profound insights into various aspects of life based on zodiac signs. For ...

According to the official website, the Jelly Tide system is positioned as a comprehensive approach to supporting a better ...

Rebounded to $10.5 million with resumption of Oil Marketing Company shipments under new contracts. India IPO Progress -- Eric ...

JNJ-4804 demonstrated highest rates of clinical and endoscopic outcomes compared to golimumab and guselkumab in patients with ulcerative colitis or Crohn's disease ...

CNW/ - Arras Minerals Corp. (TSXV: ARK) (OTCQB: ARRKF) ("Arras" or the "Company") is pleased to announce the commencement of ...

Your daily cup of coffee may be quietly reshaping your brain through your gut. A new study published in Nature Communications ...

The human gut harbors a complex ecosystem of trillions of microorganisms (the microbiome), which influences digestion, the ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-Q) from The Globe and Mail including charting and trades.

Overview of Thyroid Disorders Thyroid disorders are increasingly prevalent today, especially among women. This condition ...

Johnson & Johnson today announced results from the Phase 3 FUZION study evaluating TREMFYA® (guselkumab) in adults with active perianal fistulizing Crohn's disease (CD). At Week 24, TREMFYA ...

A total of 962 metres were completed across four (4) reconnaissance drill holes at the Upper Prawn Lake, Southside, and Crab ...

Today, AbbVie has announced two positive updates for Canadians living with UC, including those in Ontario and Alberta. To date, SKYRIZI® (risankizumab) has been listed for the treatment of UC on the ...